[1]杨 帅.酪酸梭菌活菌散剂在治疗新生儿高胆红素血症中的作用[J].医学信息,2019,32(23):147-148.[doi:10.3969/j.issn.1006-1959.2019.23.045]
　YANG Shuai.The Role of Clostridium Butyricum Powder in the Treatment of Neonatal Hyperbilirubinemia[J].Medical Information,2019,32(23):147-148.[doi:10.3969/j.issn.1006-1959.2019.23.045]
点击复制

酪酸梭菌活菌散剂在治疗新生儿高胆红素血症中的作用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年23期
页码:
147-148
栏目:
药物与临床
出版日期:
2019-12-01

文章信息/Info

Title:
The Role of Clostridium Butyricum Powder in the Treatment of Neonatal Hyperbilirubinemia
文章编号:
1006-1959（2019）23-0147-02
作者:
杨 帅
（江西省瑞金市人民医院新生儿科，江西 瑞金 342500）
Author(s):
YANG Shuai
(Department of Neonatology,Ruijin People’s Hospital,Ruijin 342500,Jiangxi,China)
关键词:
酪酸梭菌活菌散剂; 新生儿; 高胆红素血症
Keywords:
Clostridium butyricum powder; Newborn; Hyperbilirubinemia
分类号:
R722.17
DOI:
10.3969/j.issn.1006-1959.2019.23.045
文献标志码:
A
摘要:
目的 分析酪酸梭菌活菌散剂在治疗新生儿高胆红素血症中的作用。方法 选择2017年4月~2019年3月在我院诊治的200例高胆红素血症新生儿，采用随机数字表法分为对照组和观察组，各100例。对照组采用蓝光照射等对症治疗，观察组在对照组基础上采用酪酸梭菌活菌散剂治疗，比较两组临床治疗总有效率、治疗前、治疗1、3、5 d血清总胆红素水平、黄疸消退时间、不良反应发生率。结果 观察组治疗总有效率为95.00%，高于对照组的82.00%，差异有统计学意义（P＜0.05）；观察组治疗1、3、5 d血清总胆红素水平均低于对照组，差异有统计学意义（P＜0.05）；观察组黄疸消退时间为（4.71±1.80）d，短于对照组的（6.23±2.56）d，差异有统计学意义（P＜0.05）；观察组临床不良反应发生率为12.00%，低于对照组的28.00%，差异有统计学意义（P＜0.05）。结论 酪酸梭菌活菌散剂辅助治疗新生儿高胆红素血症疗效显著，可缩短黄疸消退时间，且不良反应少，用药安全可靠，值得临床应用。
Abstract:
Objective To analyze the role of Clostridium butyricum powder in the treatment of neonatal hyperbilirubinemia. Methods A total of 200 neonates with hyperbilirubinemia who were treated in our hospital from April 2017 to March 2019 were randomly divided into the control group and the observation group, 100 cases each. The control group was treated with blue light and other symptomatic treatments. The observation group was treated with Clostridium butyricum powder on the basis of the control group. The total effective rate of the two groups was compared, and the serum total bilirubin level was measured before treatment and at 1, 3, and 5 d jaundice regression time, incidence of adverse reactions. Results The total effective rate of the observation group was 95.00%, which was higher than 82.00% of the control group,the difference was statistically significant (P<0.05). The serum total bilirubin level in the observation group was lower than that of the control group at 1, 3, and 5 d,the difference was statistically significant (P<0.05). The time of jaundice regression in the observation group was (4.71±1.80) d, which was shorter than that of the control group (6.23±2.56) d, the difference was statistically significant (P<0.05). The incidence of adverse reactions was 12.00%, which was lower than that of the control group 28.00%,the difference was statistically significant (P<0.05). Conclusion Clostridium butyricum powder is effective in the treatment of neonatal hyperbilirubinemia, which can shorten the time of jaundice regression, and has fewer adverse reactions. The medication is safe and reliable and worthy of clinical application.

参考文献/References:

[1]凌万里,钱建青,周剑峰,等.茵陈颗粒辅助治疗新生儿高胆红素血症的退黄机制初探[J].儿科药学杂志,2014,20(4):9-12.[2]孙洁,林方.酪酸梭菌活菌散剂辅助治疗新生儿高胆红素血症临床效果分析[J].医学综述,2016,22(3):594-595,599.[3]黄丽娜,林玉波.观察蓝光光疗联合酪酸梭菌活菌散治疗新生儿高胆红素血症的临床疗效[J].中国医药指南,2015,13(18):141-142.[4]李旭斌,李锁更,张贤.酪酸梭菌活菌散联合蓝光治疗新生儿高胆红素血症[J].基层医学论坛,2014,18(S1):55-57.[5]孟庆华,张立明,张效民,等.新生儿重症高胆红素血症临床高危因素的条件Logistic回归分析[J].中国优生与遗传杂志,2014,22(4):92-94,118.

相似文献/References:

[1]包克珍,许云丽.新生儿社区获得性肺炎的临床特征分析[J].医学信息,2018,31(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
　BAO Ke-zhen,XU Yun-li.Clinical Characteristics of Neonatal Community Acquired Pneumonia[J].Medical Information,2018,31(23):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
[2]王 静,姜 娟,肖 婷,等.单胎足月新生儿神经行为NBNA评分相关影响因素研究[J].医学信息,2018,31(06):74.[doi:10.3969/j.issn.1006-1959.2018.06.023]
　WANG Jing,JIANG Juan,XIAO Ting,et al.Study on the Related Factors of Neurobehavioral NBNA Score in Single Term Neonates[J].Medical Information,2018,31(23):74.[doi:10.3969/j.issn.1006-1959.2018.06.023]
[3]赵凤艳.蓝光照射联合白蛋白静脉滴注对新生儿黄疸的疗效观察[J].医学信息,2018,31(09):117.[doi:10.3969/j.issn.1006-1959.2018.09.035]
　ZHAO Feng-yan.Efficacy of Blue Light Irradiation Combined with Intravenous Drip of Albumin on Neonatal Jaundice[J].Medical Information,2018,31(23):117.[doi:10.3969/j.issn.1006-1959.2018.09.035]
[4]孙继飞,张 岚.肺表面活性物质治疗足月新生儿急性呼吸窘迫综合征疗效观察[J].医学信息,2019,32(02):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
　SUN Ji-fei,ZHANG Lan.Therapeutic Effect of Pulmonary Surfactant on Acute Respiratory Distress Syndrome in Full-term Neonates[J].Medical Information,2019,32(23):121.[doi:10.3969/j.issn.1006-1959.2019.02.034]
[5]王 晖.新生儿出生体温管理与新生儿低血糖症临床相关性[J].医学信息,2018,31(15):86.[doi:10.3969/j.issn.1006-1959.2018.15.026]
　WANG Hui.Clinical Correlation Between Neonatal Temperature Management and Neonatal Hypoglycemia[J].Medical Information,2018,31(23):86.[doi:10.3969/j.issn.1006-1959.2018.15.026]
[6]朱 滨,蒋晓宏.血清NSE、hs-CRP与头颅MRI在新生儿脑损伤严重程度的相关性研究[J].医学信息,2022,35(12):130.[doi:10.3969/j.issn.1006-1959.2022.12.031]
　ZHU Bin,JIANG Xiao-hong.Correlation Between Serum NSE, hs-CRP and Brain MRI in Neonatal Brain Injury Severity[J].Medical Information,2022,35(23):130.[doi:10.3969/j.issn.1006-1959.2022.12.031]
[7]陈海燕,陈冠初.新生儿缺血缺氧性脑病的影像学诊断现状[J].医学信息,2022,35(13):53.[doi:10.3969/j.issn.1006-1959.2022.13.011]
　CHEN Hai-yan,CHEN Guan-chu.Imaging Diagnosis of Neonatal Hypoxic Ischemic Encephalopathy[J].Medical Information,2022,35(23):53.[doi:10.3969/j.issn.1006-1959.2022.13.011]
[8]陈倩如.某院住院新生儿病种构成特点分析[J].医学信息,2019,32(05):139.[doi:10.3969/j.issn.1006-1959.2019.05.044]
　CHEN Qian-ru.Analysis of the Characteristics of Neonatal Diseases in a Hospital[J].Medical Information,2019,32(23):139.[doi:10.3969/j.issn.1006-1959.2019.05.044]
[9]江乐川.新生儿无创呼吸机防治新生儿呼吸窘迫综合征的效果[J].医学信息,2019,32(22):107.[doi:10.3969/j.issn.1006-1959.2019.22.034]
　JIANG Le-chuan.Effect of Neonatal Non-invasive Ventilator on Prevention and Treatment of Neonatal Respiratory Distress Syndrome[J].Medical Information,2019,32(23):107.[doi:10.3969/j.issn.1006-1959.2019.22.034]
[10]徐咏梅.听力筛查联合遗传性耳聋基因检测在新生儿筛查中的应用[J].医学信息,2020,33(01):177.[doi:10.3969/j.issn.1006-1959.2020.01.059]
　XU Yong-mei.Hearing Screening Combined with Hereditary Deafness Gene Detection in Newborn Screening[J].Medical Information,2020,33(23):177.[doi:10.3969/j.issn.1006-1959.2020.01.059]

更新日期/Last Update: 2019-12-01